Literature DB >> 11811562

Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts.

D L Thompson1, Y Sabbagh, H S Tenenhouse, P C Roche, M K Drezner, J L Salisbury, J P Grande, E M Poeschla, R Kumar.   

Abstract

PHEX, a phosphate-regulating gene with homologies to endopeptidases on the X chromosome, is mutated in X-linked hypophosphatemia (XLH) in humans and mice (Hyp). Although recent observations indicate that Phex protein is expressed primarily in bone and may play an important role in osteoblast function and bone mineralization, the pattern of the Phex protein expression in the developing skeleton and its subcellular localization in osteoblasts remain unknown. We examined the ontogeny of the Phex protein in the developing mouse embryo and its subcellular localization in osteoblasts using a specific antibody to the protein. Immunohistochemical staining of mouse embryos revealed expression of Phex in osteogenic precursors in developing vertebral bodies and developing long bones on day 16 postcoitum (pc) and thereafter. Calvaria from day 18 pc mice showed Phex epitopes in osteoblasts. No Phex immunoreactivity was detected in lung, heart, hepatocytes, kidney, intestine, skeletal muscle, or adipose tissue of mouse embryos. Interestingly, embryonic mouse skin showed moderate amounts of Phex immunostaining. In postnatal mice, Phex expression was observed in osteoblasts and osteocytes. Moderate expression of Phex was seen in odontoblasts and slight immunoreactivity was observed in ameloblasts. Confocal microscopy revealed the presence of immunoreactive PHEX protein in the Golgi apparatus and endoplasmic reticulum of osteoblasts from normal mice and in osteoblasts from Hyp mice transduced with a human PHEX viral expression vector. PHEX protein was not detected in untransduced Hyp osteoblasts. These data indicate that Phex protein is expressed in osteoblasts and osteocytes during the embryonic and postnatal periods and that within bone, Phex may be a unique marker for cells of the osteoblast/osteocyte lineage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11811562     DOI: 10.1359/jbmr.2002.17.2.311

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  29 in total

1.  A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.

Authors:  Shoji Ichikawa; Anthony M Austin; Amie K Gray; Michael J Econs
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

Review 2.  Endocrine functions of bone in mineral metabolism regulation.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

3.  Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.

Authors:  Katherine Ann Staines; Dongxing Zhu; Colin Farquharson; Vicky Elizabeth MacRae
Journal:  J Bone Miner Metab       Date:  2013-08-08       Impact factor: 2.626

4.  Dspp-independent Effects of Transgenic Trps1 Overexpression on Dentin Formation.

Authors:  C G Mobley; M Kuzynski; H Zhang; P Jani; C Qin; D Napierala
Journal:  J Dent Res       Date:  2015-05-21       Impact factor: 6.116

5.  Dual role of the Trps1 transcription factor in dentin mineralization.

Authors:  Maria Kuzynski; Morgan Goss; Massimo Bottini; Manisha C Yadav; Callie Mobley; Tony Winters; Anne Poliard; Odile Kellermann; Brendan Lee; Jose Luis Millan; Dobrawa Napierala
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

6.  Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice.

Authors:  Andrew C Karaplis; Xiuying Bai; Jean-Pierre Falet; Carolyn M Macica
Journal:  Endocrinology       Date:  2012-10-04       Impact factor: 4.736

Review 7.  Osteocytes: master orchestrators of bone.

Authors:  Mitchell B Schaffler; Wing-Yee Cheung; Robert Majeska; Oran Kennedy
Journal:  Calcif Tissue Int       Date:  2013-09-17       Impact factor: 4.333

Review 8.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.

Authors:  Céline Gaucher; Odile Walrant-Debray; Thy-Minh Nguyen; Laure Esterle; Michèle Garabédian; Frédéric Jehan
Journal:  Hum Genet       Date:  2009-02-15       Impact factor: 4.132

10.  Functional heterogeneity of osteocytes in FGF23 production: the possible involvement of DMP1 as a direct negative regulator.

Authors:  Ji-Won Lee; Akira Yamaguchi; Tadahiro Iimura
Journal:  Bonekey Rep       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.